Literature DB >> 3730222

Left atrial rupture in osteogenesis imperfecta.

M E Rogerson, J D Buchanan, C M Morgans.   

Abstract

A 60 year old man with features of osteogenesis imperfecta presented in biventricular failure with evidence of mitral regurgitation. He responded to conventional treatment but later collapsed and died at home. Necropsy showed a haemopericardium caused by a tear in the left atrium. There was also rupture of the mitral chordae tendineae.

Entities:  

Mesh:

Year:  1986        PMID: 3730222      PMCID: PMC1236834          DOI: 10.1136/hrt.56.2.187

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  8 in total

1.  CARDIOVASCULAR ABNORMALITIES IN OSTEOGENESIS IMPERFECTA.

Authors:  M G CRISCITIELLO; J A RONAN; E M BESTERMAN; W SCHOEHWETTER
Journal:  Circulation       Date:  1965-02       Impact factor: 29.690

2.  Mitral valve disease and open heart surgery in osteogenesis imperfecta tarda.

Authors:  S J Wood; J Thomas; M V Braimbridge
Journal:  Br Heart J       Date:  1973-01

3.  Osteogenesis imperfecta 1984.

Authors:  R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

4.  The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material.

Authors:  M J Davies; B P Moore; M V Braimbridge
Journal:  Br Heart J       Date:  1978-05

5.  Prevalence of clinical mitral-valve prolapse in 1169 young women.

Authors:  P M Procacci; S V Savran; S L Schreiter; A L Bryson
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

6.  Osteogenesis imperfecta: an expanding panorama of variants.

Authors:  D Sillence
Journal:  Clin Orthop Relat Res       Date:  1981-09       Impact factor: 4.176

7.  Valvular heart disease in osteogenesis imperfecta.

Authors:  D Stein; F E Kloster
Journal:  Am Heart J       Date:  1977-11       Impact factor: 4.749

8.  Cardiovascular abnormalities in osteogenesis imperfecta.

Authors:  N J White; C G Winearls; R Smith
Journal:  Am Heart J       Date:  1983-12       Impact factor: 4.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.